X-37803981-G-T

Variant summary

Our verdict is Uncertain significance. The variant received 2 ACMG points: 4P and 2B. PM1PM2BP4_Moderate

The NM_000397.4(CYBB):​c.1002G>T​(p.Lys334Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000000911 in 1,097,850 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 1 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar. Synonymous variant affecting the same amino acid position (i.e. K334K) has been classified as Benign.

Frequency

Genomes: not found (cov: 22)
Exomes 𝑓: 9.1e-7 ( 0 hom. 1 hem. )

Consequence

CYBB
NM_000397.4 missense

Scores

1
16

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.153

Publications

0 publications found
Variant links:
Genes affected
CYBB (HGNC:2578): (cytochrome b-245 beta chain) Cytochrome b (-245) is composed of cytochrome b alpha (CYBA) and beta (CYBB) chain. It has been proposed as a primary component of the microbicidal oxidase system of phagocytes. CYBB deficiency is one of five described biochemical defects associated with chronic granulomatous disease (CGD). In this disorder, there is decreased activity of phagocyte NADPH oxidase; neutrophils are able to phagocytize bacteria but cannot kill them in the phagocytic vacuoles. The cause of the killing defect is an inability to increase the cell's respiration and consequent failure to deliver activated oxygen into the phagocytic vacuole. [provided by RefSeq, Jul 2008]
CYBB Gene-Disease associations (from GenCC):
  • granulomatous disease, chronic, X-linked
    Inheritance: XL Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, G2P
  • chronic granulomatous disease
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • X-linked Mendelian susceptibility to mycobacterial diseases due to CYBB deficiency
    Inheritance: Unknown, XL Classification: SUPPORTIVE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Orphanet

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_000397.4, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 2 ACMG points.

PM1
In a hotspot region, there are 3 aminoacids with missense pathogenic changes in the window of +-8 aminoacids around while only 0 benign, 3 uncertain in NM_000397.4
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.2125302).

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000397.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CYBB
NM_000397.4
MANE Select
c.1002G>Tp.Lys334Asn
missense
Exon 9 of 13NP_000388.2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CYBB
ENST00000378588.5
TSL:1 MANE Select
c.1002G>Tp.Lys334Asn
missense
Exon 9 of 13ENSP00000367851.4P04839
ENSG00000250349
ENST00000465127.1
TSL:5
c.171+377981G>T
intron
N/AENSP00000417050.1B4E171
CYBB
ENST00000968558.1
c.1002G>Tp.Lys334Asn
missense
Exon 9 of 14ENSP00000638617.1

Frequencies

GnomAD3 genomes
Cov.:
22
GnomAD4 exome
AF:
9.11e-7
AC:
1
AN:
1097850
Hom.:
0
Cov.:
31
AF XY:
0.00000275
AC XY:
1
AN XY:
363404
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
26375
American (AMR)
AF:
0.00
AC:
0
AN:
35132
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
19374
East Asian (EAS)
AF:
0.00
AC:
0
AN:
30196
South Asian (SAS)
AF:
0.00
AC:
0
AN:
54146
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
40529
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4131
European-Non Finnish (NFE)
AF:
0.00000119
AC:
1
AN:
841889
Other (OTH)
AF:
0.00
AC:
0
AN:
46078

Age Distribution

Exome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
22

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.12
BayesDel_addAF
Benign
-0.16
T
BayesDel_noAF
Benign
-0.46
CADD
Benign
9.7
DANN
Benign
0.96
DEOGEN2
Uncertain
0.57
D
FATHMM_MKL
Benign
0.10
N
LIST_S2
Benign
0.59
T
M_CAP
Benign
0.085
D
MetaRNN
Benign
0.21
T
MetaSVM
Benign
-0.58
T
MutationAssessor
Benign
1.8
L
PhyloP100
0.15
PrimateAI
Benign
0.27
T
PROVEAN
Benign
-1.3
N
REVEL
Benign
0.094
Sift
Benign
0.31
T
Sift4G
Benign
0.30
T
Varity_R
0.16
gMVP
0.89
Mutation Taster
=86/14
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs2228117;
hg19: chrX-37663234;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.